Search Articles — Sudonull

https://sudonull.com/rf-ai-law-vs-ai-act-comparison

Comparing the Russian AI law project and the European AI Act: risks, sovereignty, fines, TDM. What awaits developers in 2026–2027? Analysis for IT specialists.

https://sudonull.com/ai-superapp-trend-2026-global-markets-and-technologies

Analysis of Global AI-Superapp Trends: China, USA, Turkey, and Russia. How products on top of models create value. Learn why model orchestration is the key to success.

https://sudonull.com/russian-language-ai-for-x-ray-analysis-assembling-vit-rugpt-3-model

Practical guide to creating a multimodal AI model for generating medical reports in Russian. Study the architecture, data preparation, and training.

https://sudonull.com/ai-and-the-labor-market-2025-how-it-specialists-adapt-to-new-realities

Analysis of the transformation of the Russian IT market: superjuniors, AI optimization, survival strategies for senior developers. Get key career recommendations.

https://sudonull.com/voice-input-claude-russian-offline

Set up local Whisper for dictation in Claude.ai: Flask server, rumps Menu Bar, Chrome MV3. Offline, free, no limits. Instructions for Mac with code.

https://ymaho.com/growth-of-financial-pyramids-by-9-central-bank-of-the-russian-federation-and-crypto-scammers

The Central Bank identified 656 pseudo-investment projects in cryptocurrencies and AI. Learn how DeFi pyramids work and why blocking is ineffective. Read the analysis.

https://ymaho.com/portable-colposcope-with-ai-the-hidden-meaning-of-the-launch

Analysis of the launch of an AI colposcope in Russia: who benefits from the digitalization of gynecology and who loses. Learn the real consequences for medicine.

https://ymaho.com/russian-stock-market-central-bank-cuts-rate-to-14-5-growth-subdued

Moscow Exchange and RTS added 0.1%, recovering from the Central Bank rate cut to 14.5% and oil at $106. Find out why the market did not show rapid growth and which stocks became leaders after the regulator's decision.

https://ymaho.com/russian-market-opened-mixed-moscow-exchange-seeks-path-on-geopolitics

Moscow Exchange index turned to growth to 2704 points after a failed start. Brent at $112 puts pressure on rates. Find out why Magnit is falling by -5.1%, and Moscow Credit Bank is soaring and how retail investors are moving money from stocks to deposits.

https://ymaho.com/gene-therapy-of-aging-in-the-russian-federation-rage-blockade-and-sarcopenia-exosomes

Russian scientists are creating the world's first anti-aging drugs: RAGE gene blocker and exosome rejuvenation. The Ministry of Education and Science promises clinical use by 2030. Learn how transplantation of 'young' vesicles restores muscles and why the budget exceeds 2 trillion rubles.

https://ymaho.com/russian-mrna-cancer-vaccine-included-in-2026-state-guarantee-program

Gamaleya and FMBA cancer vaccines will become free under compulsory health insurance. CAR-T for 7 million rubles and personalized course for 5.8 million. Find out who is eligible for Oncopept and how many applications have already been approved.

https://ymaho.com/smart-drugs-for-cancer-and-hiv-russian-development

Russian scientists are creating 'smart drugs' based on nucleic acids for targeted attack on cancer and HIV. Learn about the platform of the future and personalized medicine.

https://ymaho.com/russian-stock-market-falls-for-8-weeks-reasons-and-forecast

Why has the Russian stock market been falling for the eighth week in a row despite expensive oil? Analysis of reasons: strong ruble, taxes, geopolitics. Find out analysts' forecast and what an investor should do.

https://ymaho.com/the-russian-government-wrote-off-114-billion-rubles-of-regional-debts

Mishustin announced the write-off of 114 billion rubles of debts for 21 regions. Learn how reducing debt on budget loans will support the modernization of housing and communal services and business development in the constituent entities of the Russian Federation.

https://ymaho.com/rise-of-russian-indices-why-it-s-a-trap-not-a-reversal

The Moscow Exchange index rose to 2690 points on geopolitical hopes. Analysts warn: this is a technical bounce on low volumes, not the start of a bull market. Find out why it's not time to buy.